Loading...

ANAB ANAPTYSBIO INC Company Mergers 8-K Filing

NPTY

NB

ANAPTYSBIO INC

(ANAB)

2026 8-K

Major Spin-Off Announcement

Financial Results Announced

Financial Update

Legal Dispute Filed

Stock Repurchase Update

Legal Dispute Filing

Investor Update

Financial Results

Investor Presentation Update

Business Separation Plans

Product Expansion

Financial Statements

Stock Repurchase

Financial Results

Investor Presentation

Clinical Trial Results

License Agreement

Financial Results

Financial Results Announcement

Annual Meeting of Stockholders

Earnings Reports

Financial Results Announcement

Financial Information Prese...

License Agreement with Cent...

Earnings Report

Clinical Trial Results

Management Changes

Financial Results Announcement

Annual Meeting of Stockholders

Earnings Report

Resignation and Appointment...

Financial Results Announcement

Amendment to Bylaws

Stock Repurchase Plan

Financial Update

External Links:

AnaptysBio, Inc. announced a spin-off of its subsidiary, First Tracks Biotherapeutics, which will distribute common stock as a dividend on April 20, 2026, and reported a private placement worth approximately $80 million at $13.81 per share.

AI Assistant

ANAPTYSBIO INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.